Does the immune system naturally protect against cancer?
about
The etiologic spectrum of head and neck squamous cell carcinoma in young patientsInduced Pluripotent Stem Cell as a New Source for Cancer ImmunotherapyA primer on tumour immunology and prostate cancer immunotherapyGenetic instability in the tumor microenvironment: a new look at an old neighborCombination Approaches with Immune-Checkpoint Blockade in Cancer TherapyThe concept of immune surveillance against tumors. The first theoriesCancers Related to Immunodeficiencies: Update and PerspectivesCoupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated ImmunityCancer immunotherapy: how low-level ionizing radiation can play a key role.Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission.Cancer Immunoprevention and Public Health.Modifying Dendritic Cell Activation with Plasmonic Nano VectorsAryl hydrocarbon receptor ligands in cancer: friend and foe.Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerPrognostic value of neutrophil-to-lymphocyte ratio in breast cancer.A principle of organization which facilitates broad Lamarckian-like adaptations by improvisationInterleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis.Changing the Paradigm of Cancer Screening, Prevention, and TreatmentIncreased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer PatientsPrognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsProgrammed death-1 & its ligands: promising targets for cancer immunotherapy.Post-transplantation malignancies: here today, gone tomorrow?Inhibition of mouse breast adenocarcinoma growth by ablation with intratumoral alpha-irradiation combined with inhibitors of immunosuppression and CpG.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.Tuning cancer fate: the unremitting role of host immunity.Introduction: MHC/KIR and governance of specificity.Rituximab efficiently depletes B cells in lung tumors and normal lung tissue.SERS analysis of serum for detection of early and locally advanced breast cancer.Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine originZebrafish Xenograft: An Evolutionary Experiment in Tumour Biology.Tumour inflammatory response: adding fuel to the fire?The immune system in cancer metastasis: friend or foe?Cytokeratin 17 mRNA as a prognostic marker of oral squamous cell carcinoma.Evolutionary biosemiotics and multilevel construction networks.Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.Combined Extract of Heated 4T1 and a Heat-Killed Preparation of Lactobacillus Casei in a Mouse Model of Breast Cancer.Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.
P2860
Q26741362-392968FB-D2AA-4FB6-A2ED-F94C1725D411Q26750579-FEFADEEA-DD0B-4715-9D02-B861B192D348Q26765697-F7E45C54-7980-4EF5-9005-F5316231B7FAQ26801374-6719769D-2771-40DF-ACB9-5099BC2FBACAQ28066199-B7567A00-11BC-40D7-A9BB-00056D576B02Q28073937-E4D876C4-2FF3-493D-9F2B-D8C57E0E4181Q28074182-677637FA-B506-4F41-BDB1-8B8B27A171CFQ28603015-9E64E29B-8422-49B7-A7C2-E1160571D5E8Q30235014-AD77909B-EEA3-418F-87C7-AE427D93C2CFQ33593877-011B480C-EC6B-4E77-8CD1-1177D281763CQ33646584-1C6CAA18-19F9-456C-A45D-419B1F89928DQ33906222-EBA7B77F-8696-4DD0-8EEE-EF0680F4A07EQ35458027-D1C0AC30-5AA9-4CE5-AB97-2334823AF92AQ35786634-DB106E04-2B1E-483E-9556-A4E93A8E8ECAQ35790197-FE9072AC-26B7-4070-9C66-7E4543AE7EA5Q36344038-7CCFF804-272D-4D72-AD2C-4026850BDECBQ36597474-FA94F12A-278E-4E90-B3AF-C35238AFA895Q36955677-7BFF9664-7E3A-4165-B4DD-613206D1B009Q37466640-D7A46E9C-3BEF-4918-AE6C-6B9A26B24BC0Q37483023-7BE0F18E-E8C1-4035-A01B-E71F8C693EF1Q37706629-641A3F8A-7ED8-4B7F-8567-C3A195C51B50Q38478878-D8306757-27FD-4868-B94B-7D7548EA5819Q38562062-9EBBD52C-94C3-4A3A-935A-418F1470DBBFQ38611709-081FB4F7-93B0-4888-9BF6-F89358BB91A3Q38753622-08054E40-739D-495A-B9EF-E4729341955EQ38958563-D357F890-6FF7-492A-B5DF-03C07E46D741Q39028941-57695E6C-A3F2-475E-8E0E-8C01641E9480Q39239026-57C18221-B527-439F-9199-3A2F9780C082Q39427560-2EFB73AD-7CE0-4387-8204-04E2B6DCE088Q39680704-6FED4F7D-74A8-43E8-BAF9-BFA6E64D42F2Q40645063-D695FE33-F83E-4E4C-B72C-66E984E5DC6AQ41072795-3C43038D-3544-4A40-B36C-C113392C6817Q41673632-EC691A84-8915-4491-9459-3430A2A69FE2Q41904274-C58F6BAB-0B84-4229-99C3-ABF48DCF3BE0Q42656251-56212591-FEEF-443A-865D-B3E22013A097Q45032879-CA1E3A46-33CE-4572-B0B9-23D6934CEE84Q45165887-FE13C89E-DB9D-4FA8-A50C-6FAB0AC735C8Q46066476-54D8E890-D2E3-4633-959F-94B95A354F62Q47100482-37674F68-551F-45B0-9484-2E7B70596B9EQ47111488-04E34C2E-894F-46AE-82D8-C6E46BB1A861
P2860
Does the immune system naturally protect against cancer?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Does the immune system naturally protect against cancer?
@en
type
label
Does the immune system naturally protect against cancer?
@en
prefLabel
Does the immune system naturally protect against cancer?
@en
P2860
P356
P1476
Does the immune system naturally protect against cancer?
@en
P2093
Alexandre Corthay
P2860
P356
10.3389/FIMMU.2014.00197
P577
2014-05-12T00:00:00Z